Xeris Biopharma Holdings, Inc.
XERS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001867096
In the last 90 days, Xeris Biopharma Holdings, Inc. insiders filed 0 open-market purchases and 10 sales; 242 institutions reported holding it in 13F filings for Q2 2026, worth $857.1M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Xeris Biopharma Holdings, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 97
- −4 vs. Q3 2022
- Shares held
- 53.9M
- −3.39M (−5.9%) vs. Q3 2022
- Total value
- $71.6M
- −$17.7M (−19.8%) vs. Q3 2022
- New holders
- 12
- 28 more added
- Sold out
- 16
- 29 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting XERS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 242 | $857.1M |
| Q1 2026 | 239 | $610.3M |
| Q4 2025 | 227 | $792.0M |
| Q3 2025 | 231 | $789.3M |
| Q2 2025 | 201 | $422.9M |
| Q1 2025 | 199 | $480.9M |
| Q4 2024 | 162 | $222.2M |
| Q3 2024 | 144 | $182.2M |
| Q2 2024 | 135 | $136.6M |
| Q1 2024 | 142 | $133.7M |
| Q4 2023 | 120 | $140.8M |
| Q3 2023 | 111 | $102.3M |
| Q2 2023 | 105 | $146.7M |
| Q1 2023 | 92 | $80.6M |
| Q4 2022 | 97 | $71.6M |
| Q3 2022 | 101 | $89.3M |
| Q2 2022 | 103 | $91.3M |
| Q1 2022 | 103 | $129.2M |
| Q4 2021 | 92 | $120.2M |
| Q3 2021 | 71 | $42.9M |
| Q2 2021 | 94 | $114.9M |
| Q1 2021 | 103 | $149.7M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Xeris Biopharma Holdings, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bailard, Inc. | 0 | $0 | 0.00% | −56,000−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −50,094−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −26,029−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −25,397−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −22,100−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −20,528−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −18,180−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −12,666−100.0% | Sold out |
| RTD Financial Advisors, Inc. | 0 | $0 | 0.00% | −12,957−100.0% | Sold out |
| Arkadios Wealth Advisors | 0 | $0 | 0.00% | −11,000−100.0% | Sold out |
| O'Dell Group, LLC | 0 | $0 | 0.00% | −3,316−100.0% | Sold out |
| Massmutual Trust Co FSB | 0 | $0 | 0.00% | −986−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −1,558−100.0% | Sold out |